BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23485397)

  • 1. HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation.
    Siepi F; Gatti V; Camerini S; Crescenzi M; Soddu S
    Biochim Biophys Acta; 2013 Jun; 1833(6):1443-53. PubMed ID: 23485397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop.
    Saul VV; de la Vega L; Milanovic M; Krüger M; Braun T; Fritz-Wolf K; Becker K; Schmitz ML
    J Mol Cell Biol; 2013 Feb; 5(1):27-38. PubMed ID: 23000554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).
    van der Laden J; Soppa U; Becker W
    Cell Commun Signal; 2015 Jan; 13():3. PubMed ID: 25630557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of dual specificity kinase activity of DYRK1A.
    Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
    FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIPK2-T566 autophosphorylation diversely contributes to UV- and doxorubicin-induced HIPK2 activation.
    Verdina A; Di Rocco G; Virdia I; Monteonofrio L; Gatti V; Policicchio E; Bruselles A; Tartaglia M; Soddu S
    Oncotarget; 2017 Mar; 8(10):16744-16754. PubMed ID: 28060750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Y361-auto-phosphorylation on structural plasticity of the HIPK2 kinase domain.
    Scaglione A; Monteonofrio L; Parisi G; Cecchetti C; Siepi F; Rinaldo C; Giorgi A; Verzili D; Zamparelli C; Savino C; Soddu S; Vallone B; Montemiglio LC
    Protein Sci; 2018 Mar; 27(3):725-737. PubMed ID: 29277937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.
    Yamada D; Pérez-Torrado R; Filion G; Caly M; Jammart B; Devignot V; Sasai N; Ravassard P; Mallet J; Sastre-Garau X; Schmitz ML; Defossez PA
    Oncogene; 2009 Jul; 28(27):2535-44. PubMed ID: 19448668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization.
    Polonio-Vallon T; Kirkpatrick J; Krijgsveld J; Hofmann TG
    Cell Cycle; 2014; 13(1):115-25. PubMed ID: 24196445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.
    Agnew C; Liu L; Liu S; Xu W; You L; Yeung W; Kannan N; Jablons D; Jura N
    J Biol Chem; 2019 Sep; 294(37):13545-13559. PubMed ID: 31341017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
    Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
    J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.
    Zhang Q; Wang Y
    J Proteome Res; 2007 Dec; 6(12):4711-9. PubMed ID: 17960875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of genotoxic stress response by homeodomain-interacting protein kinase 2 through phosphorylation of cyclic AMP response element-binding protein at serine 271.
    Sakamoto K; Huang BW; Iwasaki K; Hailemariam K; Ninomiya-Tsuji J; Tsuji Y
    Mol Biol Cell; 2010 Aug; 21(16):2966-74. PubMed ID: 20573984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.
    Akaike Y; Kuwano Y; Nishida K; Kurokawa K; Kajita K; Kano S; Masuda K; Rokutan K
    Oncogene; 2015 Jun; 34(26):3463-73. PubMed ID: 25151962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
    D'Orazi G; Cecchinelli B; Bruno T; Manni I; Higashimoto Y; Saito S; Gostissa M; Coen S; Marchetti A; Del Sal G; Piaggio G; Fanciulli M; Appella E; Soddu S
    Nat Cell Biol; 2002 Jan; 4(1):11-9. PubMed ID: 11780126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.
    Hikasa H; Sokol SY
    J Biol Chem; 2011 Apr; 286(14):12093-100. PubMed ID: 21285352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis.
    Di Stefano V; Rinaldo C; Sacchi A; Soddu S; D'Orazi G
    Exp Cell Res; 2004 Feb; 293(2):311-20. PubMed ID: 14729469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.
    Dauth I; Krüger J; Hofmann TG
    Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.
    Lochhead PA; Sibbet G; Morrice N; Cleghon V
    Cell; 2005 Jun; 121(6):925-36. PubMed ID: 15960979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
    Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
    Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.